Published in Ann Thorac Surg on March 01, 1999
Encouraging survival rates in patients with acute myocardial infarction treated with an intra-aortic balloon pump. Neth Heart J (2011) 0.89
Intra-aortic balloon pump counterpulsation: are we optimizing the management of cardiogenic shock? J R Soc Med (2013) 0.76
The length of the aorta from the subclavian artery to the renal artery based on computed tomographic measurements in Japanese adults. J Artif Organs (2006) 0.76
Imaging of mechanical cardiac assist devices. J Clin Imaging Sci (2011) 0.75
Comparison of effects of extra-thoracic paraaortic counterpulsation to intraaortic balloon pump on circulatory support in acute heart failure. J Cardiothorac Surg (2015) 0.75
Sternal wound infections in patients undergoing open heart surgery: randomized study comparing intracutaneous and transcutaneous suture techniques. Ann Thorac Surg (2001) 2.00
An outbreak of group B meningococcal disease: tracing the causative strain of Neisseria meningitidis by DNA fingerprinting. J Clin Microbiol (1986) 1.88
Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet (1998) 1.62
Laparoscopic resection of the pancreas: a feasibility study of the short-term outcome. Surg Endosc (2004) 1.59
Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure. Eur J Clin Invest (2001) 1.55
Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc Res (2000) 1.53
Lymphoid infiltration and prognosis in colorectal carcinoma. Br J Cancer (1984) 1.52
Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients. Eur Heart J (2001) 1.51
Extracorporeal membrane oxygenation using a centrifugal pump and a servo regulator to prevent negative inlet pressure. Ann Thorac Surg (1997) 1.50
High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes. Ann Thorac Surg (1995) 1.48
Viral safety of solvent/detergent-treated plasma. Transfusion (2000) 1.46
Different oxygenators for cardiopulmonary bypass lead to varying degrees of human complement activation in vitro. J Thorac Cardiovasc Surg (1989) 1.45
Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine. Eur J Anaesthesiol (2008) 1.43
Mortality and morbidity after coronary artery bypass surgery related to pre-operative left ventricular ejection fraction: a follow-up study. Eur Heart J (1996) 1.41
Mechanical valve replacement in congenital heart disease. J Heart Valve Dis (1996) 1.40
Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer's acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiol Scand (1995) 1.39
A magnetic resonance imaging study of modifications to the infraclavicular brachial plexus block. Anesth Analg (2000) 1.39
A comparative study of the short-term outcome following open and laparoscopic liver resection of colorectal metastases. Surg Endosc (2002) 1.27
The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatr Scand (2002) 1.18
Content and distribution of macrophages and lymphocytes in solid malignant human tumours. Int J Cancer (1979) 1.17
Transportation of critically ill patients on extracorporeal membrane oxygenation. Perfusion (2008) 1.11
Association between intraoperative cerebral microembolic signals and postoperative neuropsychological deficit: comparison between patients with cardiac valve replacement and patients with coronary artery bypass grafting. J Neurol Neurosurg Psychiatry (1998) 1.05
Intraaortic balloon pump in open heart operations: 10-year follow-up with risk analysis. Ann Thorac Surg (1998) 1.00
In situ analysis of the inflammatory cell infiltrates in colon carcinomas and in the normal colon wall. Acta Pathol Microbiol Immunol Scand A (1982) 0.99
Postoperative pain and convalescence in living kidney donors-laparoscopic versus open donor nephrectomy: a randomized study. Am J Transplant (2006) 0.99
Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population. J Thorac Cardiovasc Surg (1999) 0.99
Virtual reality simulator training equals mechanical robotic training in improving robot-assisted basic suturing skills. Surg Endosc (2006) 0.99
Cerebral microembolic signals during cardiopulmonary bypass surgery. Frequency, time of occurrence, and association with patient and surgical characteristics. Stroke (1997) 0.98
Isolation and characterization of lymphocytes and macrophages from solid, malignant human tumours. Int J Cancer (1979) 0.98
Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery. Scand J Thorac Cardiovasc Surg (1996) 0.98
Complement activation during major operations with or without cardiopulmonary bypass. J Thorac Cardiovasc Surg (1987) 0.95
A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin. Artif Organs (1995) 0.95
Carcinoma arising in a lung cyst. Scand J Thorac Cardiovasc Surg (1979) 0.94
N-Benzyl-p-toluene sulphonamide allows the recording of trains of intracellular action potentials from nerve-stimulated intact fast-twitch skeletal muscle of the rat. Exp Physiol (2005) 0.94
Evaluation of oxygenators and centrifugal pumps for long-term pediatric extracorporeal membrane oxygenation. Perfusion (2007) 0.94
Syndecan-1 plasma levels during coronary artery bypass surgery with and without cardiopulmonary bypass. Perfusion (2008) 0.94
Laparoscopic and open surgery for pheochromocytoma. BMC Surg (2001) 0.93
Complement activation in injured patients occurs immediately and is dependent on the severity of the trauma. Injury (1998) 0.91
Carcinoma of the stomach. A ten-year material. Acta Chir Scand (1976) 0.91
Agreement between PiCCO pulse-contour analysis, pulmonal artery thermodilution and transthoracic thermodilution during off-pump coronary artery by-pass surgery. Acta Anaesthesiol Scand (2006) 0.90
Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg (1997) 0.90
Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo. Ann Thorac Surg (1997) 0.89
Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg (1996) 0.89
Graft control by transit time flow measurement and intraoperative angiography in coronary artery bypass surgery. Heart Surg Forum (2001) 0.89
Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg (1992) 0.87
New biomarkers in an acute model of live Escherichia coli-induced sepsis in pigs. Scand J Immunol (2008) 0.86
Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg (1995) 0.86
The CarboMedics valve: midterm follow-up with analysis of risk factors. Ann Thorac Surg (1995) 0.86
The complement system in trauma-related and ischemic tissue damage: a brief review. Shock (1994) 0.85
Up to eight years' follow-up of 997 patients receiving the CarboMedics prosthetic heart valve. Ann Thorac Surg (1998) 0.85
Is it possible to predict outcome in pulmonary ECMO? Analysis of pre-operative risk factors. Perfusion (2008) 0.84
Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion (1999) 0.83
Transthoracic intra-aortic balloon pump in open heart operations: techniques and outcome. Scand Cardiovasc J (2001) 0.83
Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets. Perfusion (1998) 0.82
Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand (2001) 0.82
Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study. Eur J Cardiothorac Surg (1997) 0.82
Time for new concepts about measurement of complement activation by cardiopulmonary bypass? Ann Thorac Surg (1992) 0.81
Intraoperative angiography in minimally invasive direct coronary artery bypass grafting. Ann Thorac Surg (1997) 0.81
[Triage. Initial diagnosis of life-threatening injuries based on functional state and mechanism of injury]. Tidsskr Nor Laegeforen (1990) 0.81
Duration of preoperative electrocardiographic QRS complex and the incidence of heart arrest after aorto coronary bypass surgery. Scand Cardiovasc J (2000) 0.81
Pulsatile vs. non-pulsatile flow during cardiopulmonary bypass. A comparison of early postoperative changes. Scand J Thorac Cardiovasc Surg (1984) 0.80
T lymphocytes in malignant, non-lymphoid human tumours detected by esterase technique. Scand J Immunol (1980) 0.80
Cells bearing Fc receptors in human malignant solid tumours. Br J Cancer (1982) 0.80
Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo. J Thorac Cardiovasc Surg (1999) 0.80
[Catheter treatment of congenital heart defects. Arterial septal defects and open ductus arteriosus]. Tidsskr Nor Laegeforen (1997) 0.80
Thyroid function during and after cardiopulmonary bypass in children. Acta Anaesthesiol Scand (1998) 0.80
Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass. Ann Thorac Surg (1997) 0.80
Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. Artif Organs (1991) 0.79
Characterization of lymphocytes isolated from non-lymphoid human malignant tumours. Scand J Immunol (1978) 0.79
Coronary artery bypass surgery in women and in men; early and long-term results. A study of the Norwegian population adjusted by age and sex. Eur J Cardiothorac Surg (1997) 0.79
Course guidelines for minimally invasive cardiac surgery. STS/AATS Ad Hoc Committee on New Technology Assessment. American Association for Thoracic Surgery. J Thorac Cardiovasc Surg (1998) 0.79
Complement activation during cardiopulmonary bypass: comparison between the use of large volumes of plasma and dextran 70. Eur Surg Res (1988) 0.79
Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg (2000) 0.79
Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg (1991) 0.78
Magnetic resonance imaging demonstrates lack of precision in needle placement by the infraclavicular brachial plexus block described by Raj et al. Anesth Analg (1999) 0.78
Mechanical circulatory support of heart transplant patients. Transplant Proc (2001) 0.78
Corticosteroids in the treatment of blunt injury of the chest. Injury (1984) 0.78
In vitro evaluation of new surface coatings for extracorporeal circulation. Perfusion (1999) 0.78
Liver tumors and minimally invasive surgery: a feasibility study. J Laparoendosc Adv Surg Tech A (2001) 0.78
Cell markers in stored blood. Injury (1985) 0.78
Complement activation with bubble and membrane oxygenators in aortocoronary bypass grafting. Ann Thorac Surg (1990) 0.78
White blood cell populations in patients undergoing major vascular surgery. Scand J Thorac Cardiovasc Surg (1985) 0.78
Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro. Perfusion (1997) 0.78